carbidopa and Drug Withdrawal Symptoms

carbidopa has been researched along with Drug Withdrawal Symptoms in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19902 (11.76)18.7374
1990's8 (47.06)18.2507
2000's5 (29.41)29.6817
2010's2 (11.76)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cannas, A; Fasano, A; Lang, AE; Marrosu, F; Marrosu, MG; Mulas, CS; Solla, P1
Antonini, A; Cossu, G; Mancini, F; Modugno, N; Pilleri, M; Quatrale, R; Sensi, M; Tamma, F; Zibetti, M1
Borra, S; Hauser, RA; Zesiewicz, TA1
Iyer, SS; Morgan, JC; Sethi, KD1
Brodsky, MA; Hogarth, P; Nutt, JG1
Fersel, J; Melman, A; Weinstein, P1
Cetel, M; Guilleminault, C; Philip, P1
Angrist, B; Sanfilipo, M; Wolfsohn, R1
Bravi, D; Chase, TN; Davis, TL; Mouradian, MM; Roberts, JW1
Busenbark, K; Hauser, RA; Hubble, JP; Koller, WC; Malapira, T; Olanow, CW1
Bonoma, RA; Iwuagwu, CU; Riley, D1
Heninger, GR; Kleber, HD; Kosten, TR; McDougle, CJ; Palumbo, JM; Price, LH1
Carey, RJ1
Lefeber, EJ; Rainer, C; Scheinost, NA1
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T1
Angrist, B; Wolfsohn, R1
Golubev, VL; Orlova, OR1

Reviews

1 review(s) available for carbidopa and Drug Withdrawal Symptoms

ArticleYear
Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Postgraduate medicine, 1991, Volume: 89, Issue:5

    Topics: Aged; Carbidopa; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1991

Trials

2 trial(s) available for carbidopa and Drug Withdrawal Symptoms

ArticleYear
A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 9, Issue:1

    Topics: Adult; Breath Tests; Carbidopa; Cocaine; Drug Combinations; Electrocardiography; Humans; Levodopa; Substance Withdrawal Syndrome

1993
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Selegiline; Substance Withdrawal Syndrome

2000

Other Studies

14 other study(ies) available for carbidopa and Drug Withdrawal Symptoms

ArticleYear
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:8

    Topics: Aged; Anhedonia; Apathy; Carbidopa; Dopamine Agonists; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome

2015
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up.
    Parkinsonism & related disorders, 2017, Volume: 38

    Topics: Antiparkinson Agents; Carbidopa; Disease Progression; Drug Combinations; Female; Gels; Health Surveys; Humans; Intestines; Italy; Levodopa; Longitudinal Studies; Male; Parkinson Disease; Retrospective Studies; Substance Withdrawal Syndrome

2017
Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

    Topics: Aged; Antipsychotic Agents; Carbidopa; Clozapine; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Substance Withdrawal Syndrome

2002
Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel function.
    Neurology, 2005, Nov-08, Volume: 65, Issue:9

    Topics: Administration, Oral; Aged; Carbidopa; Disease Progression; Dopamine Agents; Drug Combinations; Female; Humans; Intestinal Pseudo-Obstruction; Intestine, Small; Levodopa; Middle Aged; Parkinson Disease; Patient Selection; Substance Withdrawal Syndrome; Treatment Failure

2005
OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9

    Topics: Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Corpus Striatum; Deep Brain Stimulation; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesias; Electrodes, Implanted; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Secondary Prevention; Stereotaxic Techniques; Substance Withdrawal Syndrome; Subthalamic Nucleus

2006
Further studies on the effect of chronic alpha-methyldopa administration upon the central nervous system and sexual function in male rats.
    The Journal of urology, 1984, Volume: 132, Issue:4

    Topics: Animals; Carbidopa; Central Nervous System; Erectile Dysfunction; Humans; Libido; Male; Methyldopa; Norepinephrine; Penis; Rats; Reflex; Sexual Behavior, Animal; Substance Withdrawal Syndrome; Yohimbine

1984
Dopaminergic treatment of restless legs and rebound phenomenon.
    Neurology, 1993, Volume: 43, Issue:2

    Topics: Aged; Carbidopa; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Prospective Studies; Restless Legs Syndrome; Substance Withdrawal Syndrome

1993
End-of-dose dystonia in Parkinson's disease.
    Neurology, 1993, Volume: 43, Issue:10

    Topics: Adult; Carbidopa; Dystonia; Humans; Infusions, Intravenous; Levodopa; Middle Aged; Parkinson Disease; Selegiline; Substance Withdrawal Syndrome

1993
Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
    The American journal of medicine, 2000, Apr-15, Volume: 108, Issue:6

    Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Confusion; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Nitrophenols; Substance Withdrawal Syndrome; Tolcapone

2000
Dopaminergic responsivity during cocaine abstinence: a pilot study.
    Psychiatry research, 1992, Volume: 43, Issue:1

    Topics: Adult; Carbidopa; Cocaine; Dopamine Agents; Drug Combinations; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders

1992
Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.
    Brain research, 1991, Dec-24, Volume: 568, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Carbidopa; Corpus Striatum; Denervation; Drug Tolerance; Functional Laterality; Homovanillic Acid; Levodopa; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome

1991
Neuroleptic malignant syndrome without neuroleptics.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan

1990
A pilot trial of levodopa/carbidopa in early cocaine abstinence.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Adult; Arousal; Carbidopa; Cocaine; Drug Therapy, Combination; Humans; Levodopa; Pilot Projects; Substance Withdrawal Syndrome; Substance-Related Disorders

1990
[Phenomenon of inverted rotation in spastic torticollis].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:3

    Topics: Adult; Brain; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Muscle Spasticity; Receptors, Dopamine; Rotation; Substance Withdrawal Syndrome; Torticollis

1986